A REVIEW OF PERCOCET AND ZANAFLEX

Have not offered suitable analgesia, or are usually not envisioned to offer ample analgesia CONTRAINDICATIONSAfter stopping a CYP3A4 inducer, since the effects in the inducer decline, the oxycodone plasma focus will enhance [see CLINICAL PHARMACOLOGY], which could boost or prolong both the therapeutic effects and adverse reactions, and could cause